# The Efficacy of Preseasonal Omalizumab Treatment

> **NCT04489121** · NA · COMPLETED · sponsor: **Beijing Tongren Hospital** · enrollment: 31 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Omalizumab

## Key facts

- **NCT ID:** NCT04489121
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2020-09-26
- **Final completion:** 2020-10-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489121, "The Efficacy of Preseasonal Omalizumab Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04489121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*